newsfilter
← Latest News
GlobeNewswire·

Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs

Lead program, NEO-PTC-01, is a personalized neoantigen adoptive T cell therapy candidate to address refractory solid tumors Corporate restructuring effected to focus resources while exploring...